The method of calculation of the primarily-multiple malignant tumors (PMMT) frequency depending on their occurrence succession was supposed. The frequency of synchronous PMMT calculated in relation to total quantity of patients with mammarial gland cancer (MGC) was 1.5%. The frequency of metachronous PMMT was calculated basing on the MGC patients quantity in every year of observation. The summary frequency of metachronous PMMT for last 20 years of observation of 11512 MGC patients was 16.2%, the total PMMT frequency-17.7%, approximating to the true frequency at the end of life in all the MGC patients. The differences of metachronous PMMT revealing were established, witnessing the existence of at least two heterogenic groups of patients, in one of which the influence of some etiological factors with the determined term of the cancerogenic effect realization, causing the PMMT occurrence frequency rising were established.

Download full-text PDF

Source

Publication Analysis

Top Keywords

metachronous pmmt
12
mgc patients
12
malignant tumors
8
pmmt calculated
8
frequency metachronous
8
pmmt
7
patients
6
frequency
6
[the frequency
4
frequency detection
4

Similar Publications

A 5-year survival of patients with Stage III colon cancer with prophylactic panhysterectomy in anamnesis was 83.3%, significantly higher than that of patients with Stage III colon cancer without panhysterectomy (69.3%) and than in colon cancer patients with metachronous ovarian metastases (42%).

View Article and Find Full Text PDF

The problem of primary multiple malignant tumor (PMMT) of skin melanoma in Ukraine is analyzed. During the period from 2000 to 2006, 16760 cases of skin melanoma have been diagnosed, and in 873 patients from them PMMT has been registered. So, the part of the patients with multiple tumors among all patients with skin melanoma was 5.

View Article and Find Full Text PDF

The method of calculation of the primarily-multiple malignant tumors (PMMT) frequency depending on their occurrence succession was supposed. The frequency of synchronous PMMT calculated in relation to total quantity of patients with mammarial gland cancer (MGC) was 1.5%.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!